HealthcareServices

Immune Response Testing Market Future Outlook 2026: Key Drivers and Growth Potential

February 25, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the immune response testing market from 2026–2035 with trusted insights from The Business Research Company

What total market size is anticipated for the Immune Response Testing Market in 2030?

The immune response testing market has experienced substantial growth in its size over recent years. It is anticipated to expand from $16.36 billion in 2025 to $18.09 billion in 2026, driven by a compound annual growth rate (CAGR) of 10.6%. The historical expansion of this market can be attributed to several factors, including the increasing prevalence of immune-related disorders, the broader application of antibody-based diagnostics, the growth in clinical immunology laboratories, the rising adoption of ELISA testing methods, and more extensive vaccine response monitoring.

The immune response testing market is projected to experience substantial expansion in the coming years. This market is forecast to reach $26.76 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.3%. This projected growth is driven by factors such as the rising demand for personalized immune profiling, the increasing application of immune monitoring in oncology and vaccine development, the broadening availability of point-of-care immune testing, the expanding integration of AI in interpreting diagnostics, and a heightened emphasis on detecting immune dysfunction early. Key trends anticipated during this period involve the increasing uptake of multiplex immune assays, the growing utilization of cellular immune response analysis, the broader incorporation of automated testing platforms, the development of more high-sensitivity diagnostic panels, and a concentrated focus on immune monitoring.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27314&type=smp

What Drivers Are Influencing Production Trends In The Immune Response Testing Market?

The increasing incidence of autoimmune diseases is anticipated to fuel the expansion of the immune response testing market in the future. These diseases are characterized by the body’s immune system erroneously targeting its own healthy cells and tissues. The rising occurrence of autoimmune diseases largely stems from greater exposure to environmental contaminants, which can impair immune function and provoke immune attacks on the body’s tissues. Immune response testing improves the management of autoimmune conditions by offering accurate insights into immune activity, facilitating early detection and customized treatment strategies. This testing aids in enhanced disease monitoring and contributes to better patient outcomes via adjustments to targeted therapies. For example, data from February 2024, provided by Arthritis Australia, a non-profit organization based in Australia, projects that 562,378 Australians will have RA by 2025, constituting 14% of all arthritis cases during that year. This figure is expected to climb by 33% to 748,721 people by 2040, indicating an additional 186,343 Australians affected by RA compared to 2025. Consequently, the increasing prevalence of autoimmune diseases is driving the growth of the immune response testing market.

Which Segments Are Gaining Traction In The Immune Response Testing Market?

The immune response testing market covered in this report is segmented –

1) By Type Of Testing: Antibody Testing, Cytokine Testing, Cellular Testing, Complement System Testing

2) By Application: Allergy Testing, Human Immunodeficiency Virus (HIV) Disease, Cancer, Rheumatoid Arthritis, Systemic Lupus Erythematosus, Other Applications

3) By End-User: Hospitals And Clinics, Diagnostic Laboratories, Research Institutes, Home Care Settings

Subsegments:

1) By Antibody Testing: Immunoglobulin G (IgG) Testing, Immunoglobulin A (IgA) Testing, Immunoglobulin M (IgM) Testing, Neutralizing Antibody Testing, Rapid Antibody Testing

2) By Cytokine Testing: Enzyme-Linked Immunosorbent Assay (ELISA)-Based Cytokine Assays, Multiplex Cytokine Assays, Flow Cytometry-Based Cytokine Assays, Cytometric Bead Array, Quantitative Polymerase Chain Reaction (qPCR)-Based Cytokine Analysis

3) By Cellular Testing: T-Cell Response Assays, B-Cell Response Assays, Natural Killer (NK) Cell Assays, Lymphocyte Proliferation Assays, ELISpot Assays

4) By Complement System Testing: Total Hemolytic Complement (CH50) Assay, Alternative Pathway Hemolytic Complement (AH50) Assay, Complement Component 3 And 4 (C3 And C4) Complement Testing, Mannose-Binding Lectin (MBL) Testing, Complement Activity Assays

What Upcoming Trends Are Likely To Define The Future Path Of The Immune Response Testing Market?

Major companies within the Immune Response Testing market are concentrating on developing innovative solutions, such as immune profiling technologies, to address the increasing demand for advanced diagnostics in post-viral syndromes and for assessing adaptive immunity. These immune profiling technologies are specifically designed to analyze the immune system comprehensively, evaluating both cellular and humoral responses, thereby offering more detailed insights compared to traditional serological tests that primarily detect antibody levels. For instance, in April 2024, Virax Biolabs Group Limited, a UK-based biotechnology company, launched its portfolio of immune profiling solutions at ESCMID Global 2024, specifically targeting the evaluation of adaptive immunity in post-viral conditions. These solutions incorporate advanced assays, including multi-parametric flow cytometry and targeted biomarker panels, facilitating precise characterization of immune cell subsets and their functional responses. Notable features include high sensitivity, customizable panels suitable for various post-viral syndromes, and integration with digital reporting platforms to streamline data interpretation. Their applications extend from clinical research to personalized patient monitoring, providing benefits such as the early detection of immune dysfunction and support for informed therapeutic decision-making.

Who Are The Major Companies Operating In The Immune Response Testing Market?

Major companies operating in the immune response testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthcare GmbH, Becton Dickinson and Company, Quest Diagnostics Incorporated, Eurofins Scientific SE, PerkinElmer Inc., bioMérieux SA, Bruker Corporation, Beckman Coulter Inc., Bio-Rad Laboratories Inc., Qiagen N.V., DiaSorin S.p.A., EUROIMMUN Medizinische Labor diagnostika AG, NanoString Technologies Inc., GenScript Biotech Corporation, Cell Signaling Technology Inc., Sysmex Corporation, Ortho Clinical Diagnostics, Randox Laboratories Ltd., Merck KGaA

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/immune-response-testing-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Immune Response Testing Market?

North America was the largest region in the immune response testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the immune response testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Immune Response Testing Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=27314&type=smp

Browse Through More Reports Similar to the Global Immune Response Testing Market 2026, By The Business Research Company

Nanofibers Market Report 2026

https://www.thebusinessresearchcompany.com/report/nanofibers-global-market-report

Nanomaterials Market Report 2026

https://www.thebusinessresearchcompany.com/report/nanomaterials-global-market-report

Nanosilica Market Report 2026

https://www.thebusinessresearchcompany.com/report/nanosilica-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795